Report Detail

Pharma & Healthcare Global Demerol (Meperidine) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2474450
  • |
  • 12 October, 2018
  • |
  • Global
  • |
  • 131 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Demerol (Meperidine) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Demerol (Meperidine) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Powder
      • 1.2.2 Liquid
    • 1.3 Market Analysis by Applications
      • 1.3.1 Anesthesia
      • 1.3.2 Cough Treatment
      • 1.3.3 Diarrhea Treatment
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Purdue Pharma
      • 2.1.1 Business Overview
      • 2.1.2 Demerol (Meperidine) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Purdue Pharma Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Egalet
      • 2.2.1 Business Overview
      • 2.2.2 Demerol (Meperidine) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Egalet Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Boehringer Ingelheim
      • 2.3.1 Business Overview
      • 2.3.2 Demerol (Meperidine) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Boehringer Ingelheim Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Janssen
      • 2.4.1 Business Overview
      • 2.4.2 Demerol (Meperidine) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Janssen Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Sanofi
      • 2.5.1 Business Overview
      • 2.5.2 Demerol (Meperidine) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Sanofi Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Sun Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Demerol (Meperidine) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Sun Pharmaceuticals Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Mallinckrodt Pharmaceuticals
      • 2.7.1 Business Overview
      • 2.7.2 Demerol (Meperidine) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 Endo Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Demerol (Meperidine) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Endo Pharmaceuticals Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Actavis
      • 2.9.1 Business Overview
      • 2.9.2 Demerol (Meperidine) Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Actavis Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 Pfizer
      • 2.10.1 Business Overview
      • 2.10.2 Demerol (Meperidine) Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Pfizer Demerol (Meperidine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Demerol (Meperidine) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Demerol (Meperidine) Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Demerol (Meperidine) Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Demerol (Meperidine) Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Demerol (Meperidine) Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Demerol (Meperidine) Market Analysis by Regions

    • 4.1 Global Demerol (Meperidine) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Demerol (Meperidine) Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Demerol (Meperidine) Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 4.3 Europe Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 4.5 South America Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Demerol (Meperidine) Sales and Growth Rate (2013-2018)

    5 North America Demerol (Meperidine) by Countries

    • 5.1 North America Demerol (Meperidine) Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Demerol (Meperidine) Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Demerol (Meperidine) Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 5.3 Canada Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Demerol (Meperidine) Sales and Growth Rate (2013-2018)

    6 Europe Demerol (Meperidine) by Countries

    • 6.1 Europe Demerol (Meperidine) Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Demerol (Meperidine) Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Demerol (Meperidine) Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 6.3 UK Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 6.4 France Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 6.5 Russia Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 6.6 Italy Demerol (Meperidine) Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Demerol (Meperidine) by Countries

    • 7.1 Asia-Pacific Demerol (Meperidine) Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Demerol (Meperidine) Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Demerol (Meperidine) Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 7.3 Japan Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 7.4 Korea Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 7.5 India Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Demerol (Meperidine) Sales and Growth Rate (2013-2018)

    8 South America Demerol (Meperidine) by Countries

    • 8.1 South America Demerol (Meperidine) Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Demerol (Meperidine) Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Demerol (Meperidine) Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Demerol (Meperidine) Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Demerol (Meperidine) by Countries

    • 9.1 Middle East and Africa Demerol (Meperidine) Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Demerol (Meperidine) Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Demerol (Meperidine) Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 9.3 UAE Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Demerol (Meperidine) Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Demerol (Meperidine) Sales and Growth Rate (2013-2018)

    10 Global Demerol (Meperidine) Market Segment by Type

    • 10.1 Global Demerol (Meperidine) Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Demerol (Meperidine) Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Demerol (Meperidine) Revenue and Market Share by Type (2013-2018)
    • 10.2 Powder Sales Growth and Price
      • 10.2.1 Global Powder Sales Growth (2013-2018)
      • 10.2.2 Global Powder Price (2013-2018)
    • 10.3 Liquid Sales Growth and Price
      • 10.3.1 Global Liquid Sales Growth (2013-2018)
      • 10.3.2 Global Liquid Price (2013-2018)

    11 Global Demerol (Meperidine) Market Segment by Application

    • 11.1 Global Demerol (Meperidine) Sales Market Share by Application (2013-2018)
    • 11.2 Anesthesia Sales Growth (2013-2018)
    • 11.3 Cough Treatment Sales Growth (2013-2018)
    • 11.4 Diarrhea Treatment Sales Growth (2013-2018)

    12 Demerol (Meperidine) Market Forecast (2018-2023)

    • 12.1 Global Demerol (Meperidine) Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Demerol (Meperidine) Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Demerol (Meperidine) Market Forecast (2018-2023)
      • 12.2.2 Europe Demerol (Meperidine) Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Demerol (Meperidine) Market Forecast (2018-2023)
      • 12.2.4 South America Demerol (Meperidine) Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Demerol (Meperidine) Market Forecast (2018-2023)
    • 12.3 Demerol (Meperidine) Market Forecast by Type (2018-2023)
      • 12.3.1 Global Demerol (Meperidine) Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Demerol (Meperidine) Market Share Forecast by Type (2018-2023)
    • 12.4 Demerol (Meperidine) Market Forecast by Application (2018-2023)
      • 12.4.1 Global Demerol (Meperidine) Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Demerol (Meperidine) Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.

      Scope of the Report:
      This report focuses on the Demerol (Meperidine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
      An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.
      The worldwide market for Demerol (Meperidine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers
      Purdue Pharma
      Egalet
      Boehringer Ingelheim
      Janssen
      Sanofi
      Sun Pharmaceuticals
      Mallinckrodt Pharmaceuticals
      Endo Pharmaceuticals
      Actavis
      Pfizer

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Powder
      Liquid

      Market Segment by Applications, can be divided into
      Anesthesia
      Cough Treatment
      Diarrhea Treatment

      There are 15 Chapters to deeply display the global Demerol (Meperidine) market.
      Chapter 1, to describe Demerol (Meperidine) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
      Chapter 2, to analyze the top manufacturers of Demerol (Meperidine), with sales, revenue, and price of Demerol (Meperidine), in 2016 and 2017;
      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
      Chapter 4, to show the global market by regions, with sales, revenue and market share of Demerol (Meperidine), for each region, from 2013 to 2018;
      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
      Chapter 12, Demerol (Meperidine) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
      Chapter 13, 14 and 15, to describe Demerol (Meperidine) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


      Summary:
      Get latest Market Research Reports on Demerol (Meperidine) . Industry analysis & Market Report on Demerol (Meperidine) is a syndicated market report, published as Global Demerol (Meperidine) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Demerol (Meperidine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,766.03
      4,149.05
      5,532.07
      3,100.83
      4,651.25
      6,201.67
      377,799.24
      566,698.86
      755,598.48
      243,138.90
      364,708.35
      486,277.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report